Taiwanese Pharmaceuticals & Biotech Big Green Snowflakes

PharmaEngine

Market Cap: NT$13.0b

A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.

TTY Biopharm

Market Cap: NT$18.7b

Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally.

PharmaEssentia

Market Cap: NT$166.4b

A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.

SYN-TECH Chem. & Pharm

Market Cap: NT$4.0b

Manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally.

Lotus Pharmaceutical

Market Cap: NT$61.5b

Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.

Chi Sheng Pharma & Biotech

Market Cap: NT$1.7b

Engages in the manufacturing, processing, sale, and import and export trade of pharmaceuticals, medical products, cosmetics, health foods, and medical equipment in Taiwan and internationally.

YungShin Global Holding

Market Cap: NT$16.3b

Through its subsidiaries, invests in, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicines, and cosmetics.

TSH Biopharm

Market Cap: NT$1.9b

Develops and markets pharmaceutical products in Taiwan and Asia.

RBC Bioscience

Market Cap: NT$243.3m

Researches, develops, manufactures, and sells reagents and devices for life science and molecular diagnosis in Europe, the United States, Asia, Taiwan, Africa, and Australia.

Nang Kuang Pharmaceutical

Market Cap: NT$3.7b

Manufactures, processes, trades in, imports, and exports pharmaceuticals and medical devices in Taiwan, China, Japan, the United States, and internationally.

Maxigen Biotech

Market Cap: NT$3.9b

Researches, develops, produces, and sells implantable medical devices and cosmetic products in Taiwan, America, Europe, rest of Asia, and internationally.

Bora Pharmaceuticals

Market Cap: NT$79.5b

Researches and develops, manufactures, distributes, and sells pharmaceuticals worldwide.

Standard Chemical & Pharmaceutical

Market Cap: NT$10.5b

Standard Chemical & Pharmaceutical Co. Ltd.

DV Biomed

Market Cap: NT$1.5b

Manufactures and sells medical-grade skin care products in Taiwan and China.

Yung Zip Chemical Ind

Market Cap: NT$1.0b

A bulk drug manufacturing company, supplies active pharmaceutical ingredients (APIs), API intermediates, and specialty chemicals worldwide.

SunWay Biotech

Market Cap: NT$3.8b

Focuses on professional research and development, and technical material manufacturing and processing business.

Ever Supreme Bio Technology

Market Cap: NT$13.6b

Engages in the research, development, and manufacture of drug products related to human mesenchymal stem cells and immune cells in Taiwan.

Allied Biotech

Market Cap: NT$1.7b

Manufactures and sells carotenoids worldwide.

Sinphar PharmaceuticalLtd

Market Cap: NT$6.0b

Engages in the production, processing, selling, and trading of various medicines, Chinese medicines, medical cosmetic products and nutrients in Taiwan, Mainland China, Vietnam, Indonesia, and internationally.

Formosa Laboratories

Market Cap: NT$8.5b

Manufactures and sells active pharmaceutical ingredients (APIs) and ultraviolet absorbers in India, the Netherlands, Japan, Germany, Taiwan, China, Switzerland, the United States, Canada, and internationally.

Cenra

Market Cap: NT$3.3b

Engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals.

TCM Biotech International

Market Cap: NT$3.4b

A biotech company, engages in the research and development of drugs for the prevention and treatment of liver diseases.

Synmosa Biopharma

Market Cap: NT$15.5b

A specialty pharmaceutical company, researches, develops, manufactures, markets, and distributes pharmaceutical and healthcare products under the Synmosa brand name in Taiwan.

SCI Pharmtech

Market Cap: NT$8.1b

Together with its subsidiary, engages in the research and development, manufacture, and sale of active pharmaceutical ingredients, intermediates, and specialty chemicals in Italy, the United States, Japan, Germany, Taiwan, Switzerland, China, and internationally.

Winston Medical Supply

Market Cap: NT$1.9b

Winston Medical Supply Co.,Ltd. develops, manufactures, and distributes pharmaceuticals, nutrition supplements, and cosmeceutical products in Taiwan and internationally.

Orient Pharma

Market Cap: NT$7.1b

Engages in the research and development, manufacturing, and sales of drugs in Taiwan and internationally.

HeXun Biosciences

Market Cap: NT$3.3b

Engages in the research and development of stem cell and treatments in Taiwan.

Anxo Pharmaceutical

Market Cap: NT$1.1b

A specialty pharmaceutical company, develops, manufactures, and sells pharmaceutical products for medical professionals and patients in Taiwan and internationally.

Genetics Generation Advancement

Market Cap: NT$1.4b

Provides genetic testing and informatics services in Taiwan.

Sunmax Biotechnology

Market Cap: NT$21.8b

A biomedical company, develops, manufactures, and markets collagen-based medical devices in Taiwan and Mainland China.

BioLASCO Taiwan

Market Cap: NT$858.0m

Provides bio-materials and surgical services in Taiwan and internationally.

Savior Lifetec

Market Cap: NT$6.8b

A specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations.

Johnson Chemical Pharmaceutical Works

Market Cap: NT$2.9b

Johnson Chemical Pharmaceutical Works Co., Ltd.

Caliway Biopharmaceuticals

Market Cap: NT$135.6b

Engages in the development of drugs for aesthetic medicine and chronic inflammation.

Syngen BiotechLtd

Market Cap: NT$3.8b

Engages in the research, development, manufacturing, and sale of microbial pharmaceutical raw materials, biological pesticides, fertilizers and biochemical nutritional products, and preventive medicines in Taiwan, China, and internationally.

GlycoNex Incorporation

Market Cap: NT$2.7b

Engages in the development of cancer drugs using glycosphingolipid antigen and human monoclonal antibody technologies in Taiwan.